These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7456470)

  • 1. [The plasma prolactin level under fluphenazine treatment (author's transl)].
    Hinterhuber H; Platz T; Schwarz S
    Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug-response differences of high and standard dosage of fluphenazine-decanoate in relation to schizophrenic symptoms (author's transl)].
    Lehmann E; Quadbeck H; Tegeler J; Fararuni M; Heinrich K
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):117-29. PubMed ID: 7393998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA; Silver MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
    Wiles DH; Gelder MG
    Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)].
    Müller P; Kind J; Steuber H
    Arzneimittelforschung; 1978; 28(9):1501-2. PubMed ID: 383099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluphenazine dihydrochloride--a multicenter trial on 660 patients (author's transl)].
    Pieschl D; Kulhanek F; Piergies A
    Arzneimittelforschung; 1978; 28(9):1503-4. PubMed ID: 383100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW; Kulhanek F
    Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circadian behavior of plasma testosterone and gonadotropins during hyperprolactinemia induced by administration of fluphenazine decanoate].
    Magnatta R; Spallone L; Camagna A; Reda G; Bersani G; Dotti A; Lauro R
    Clin Ter; 1980 Mar; 92(5):469-75. PubMed ID: 7449324
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.
    Jakovljevic M; Pivac N; Mihaljevic-Peles A; Mustapic M; Relja M; Ljubicic D; Marcinko D; Muck-Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):399-402. PubMed ID: 17126974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine plasma levels and clinical response.
    Marder SR; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J; Midha KK
    Psychopharmacol Bull; 1990; 26(2):256-9. PubMed ID: 2236467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.
    Norman TR; Marriott PF; Kimber NM; Burrows GD
    Int Clin Psychopharmacol; 1987 Oct; 2(4):299-305. PubMed ID: 3693869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of schizophrenic psychoses with Lyorodin].
    Schulz HD; Kluge HH; Korda W; Kube B
    Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):360-6. PubMed ID: 918199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The behaviour of visually evoked potentials (VEP) in schizophrenia under gradually rising doses of fluphenazine dihydrochloride (author's transl)].
    Brosteanu ER; Floru L
    Arzneimittelforschung; 1977; 27(6):1231-3. PubMed ID: 578448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
    Litman RE; Hong WW; Weissman EM; Su TP; Potter WZ; Pickar D
    J Clin Psychopharmacol; 1993 Aug; 13(4):264-7. PubMed ID: 8104200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot fluphenazine and plasma prolactin.
    Gift T; Plum K; Price M
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):407-12. PubMed ID: 4070643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of endogenous hyperprolactinemia induced with administration of fluphenazine decanoate on urinary excretion of sodium and potassium].
    Spallone L; Camagna A; Magnatta R; Reda G; Dotti A; Lauro R
    Clin Ter; 1980 Feb; 92(4):389-97. PubMed ID: 7449318
    [No Abstract]   [Full Text] [Related]  

  • 20. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.